Baxter Says Novum Pump Issues Don't Show Securities Fraud
A group of Baxter International shareholders should not be allowed to pursue securities fraud claims over a new fluid pump product later deemed defective simply because the product and its revenues...To view the full article, register now.
Already a subscriber? Click here to view full article